Table 2.
Amsterdam Criteria | Germline mutation | Overall % | |
---|---|---|---|
Number of patients | |||
Segmental | 414 | 705 | 1119 |
Extensive | 94 | 176 | 270 |
Median follow up (months) | 88.0 | 95.0 | 92.8 |
Risk of MCC (%) | |||
Segmental | 22.7 | 21.8 | 22.7 |
Extensive | 7.4 | 2.8 | 4.7 |
There was no significant difference in MCC risk between Amsterdam criteria and germline mutation cohorts